| Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. Bains O.S., Grigliatti T.A., Reid R.E., Riggs K.W.
J. Pharmacol. Exp. Ther. 335:533-545(2010) |
| The effect of allelic variation in aldo-keto reductase 1C2 on the in vitro metabolism of dihydrotestosterone. Takahashi R.H., Grigliatti T.A., Reid R.E., Riggs K.W.
J. Pharmacol. Exp. Ther. 329:1032-1039(2009) · Mapped (3) |
| Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Bains O.S., Karkling M.J., Grigliatti T.A., Reid R.E., Riggs K.W.
Drug Metab. Dispos. 37:1107-1114(2009) · Mapped (2) |
| Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin. Bains O.S., Takahashi R.H., Pfeifer T.A., Grigliatti T.A., Reid R.E., Riggs K.W.
Drug Metab. Dispos. 36:904-910(2008) · UniProtKB (1) |
| Calcium-induced folding of a fragment of calmodulin composed of EF-hands 2 and 3. Lakowski T.M., Lee G.M., Okon M., Reid R.E., McIntosh L.P.
Protein Sci. 16:1119-1132(2007) · Mapped (1) |
| Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Guo X., Chambers A.F., Parfett C.L., Waterhouse P., Murphy L.C., Reid R.E., Craig A.M., Edwards D.R., Denhardt D.T.
Cell Growth Differ. 1:333-338(1990) · UniProtKB (1) · Mapped (1) |
